David R Guyer's Net Worth
$41 Million
Who is David R Guyer?
David R Guyer has an estimated net worth of $41 Million. This is based on reported shares across multiple companies, which include EYETECH PHARMACEUTICALS INC, EyePoint Pharmaceuticals, Inc., Ophthotech Corp., APPLIED GENETIC TECHNOLOGIES CORP, and OSI PHARMACEUTICALS INC.
SEC CIK
David R Guyer's CIK is 0001277476
Past Insider Trading and Trends
2015 was David R Guyer's most active year for acquiring shares with 20 total transactions. David R Guyer's most active month to acquire stocks was the month of December. 2015 was David R Guyer's most active year for disposing of shares, totalling 46 transactions. David R Guyer's most active month to dispose stocks was the month of December. 2004 saw David R Guyer paying a total of $598,200.00 for 270,000 shares, this is the most they've acquired in one year. In 2004 David R Guyer cashed out on 260,500 shares for a total of $10,164,450.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EYETECH PHARMACEUTICALS INC No price found
Chief Executive OfficerDavid R Guyer used to own units in Common Stock but no longer holds any shares there.acquired a total of 160,000 shares in EYETECH PHARMACEUTICALS INC at a cost of $1,600.00, David also disposed a total of 1,630,000 shares of EYETECH PHARMACEUTICALS INC equalling to $16,314,326.43.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.21M |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| -1.31% | -15.60K |
$11.33 | -$176,748.00 | 1.18M |
Scheduled
|
Aug 1
| ||
Form 4
| -1.29% | -15.60K |
$12.56 | -$195,936.00 | 1.19M |
Scheduled
|
Jul 1
| ||
Form 4
| +12.56% | 135K |
$0.01 | $1,350.00 | 1.21M |
Jun 28
| |||
Form 4
| -1.43% | -15.60K |
$12.95 | -$202,020.00 | 1.07M |
Scheduled
|
Jun 1
| ||
Form 4
| -8.40% | -100.00K |
$35.97 | -$3,597,000.00 | 1.09M |
Scheduled
|
Feb 1
| ||
Form 4
| -3.31% | -40.00K |
$44.70 | -$1,788,000.00 | 1.17M |
Scheduled
|
Jan 3
| ||
Form 4
| +1.70% | 20.54K |
$21.32 | -$189,922.43 | 1.23M |
Jan 5
| |||
Form 4
| -3.20% | -40.00K |
$41.88 | -$1,675,200.00 | 1.21M |
Scheduled
|
Dec 9 - Dec 21
| ||
Form 4
| -15.00% | -220.50K |
$38.50 | -$8,489,250.00 | 1.25M |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97
InvestorDavid R Guyer owns 1,850 units of Common Stock which is worth $14,744.50. From 2019 to 2024 David R Guyer acquired a total of 36,725 shares in EyePoint Pharmaceuticals, Inc. at a cost of $97,939.50, David also disposed a total of 34,875 shares of EyePoint Pharmaceuticals, Inc. equalling to $383,744.73.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -1.85K |
$6.70 | -$84,348.66 | 1.85K |
Jul 12
| |||
Form 4
| -33.33% | -1.85K |
$6.82 | -$87,058.45 | 3.7K |
Jun 3
| |||
Form 4
| -25.00% | -1.85K |
$8.00 | -$114,398.12 | 5.55K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +68.18% | 3K |
—
|
—
| 7.4K |
Feb 9
| |||
Form 4
| +131.58% | 2.5K |
—
|
—
| 4.4K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 1.9K |
—
|
—
| 1.9K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ophthotech Corp. No price found
Executive ChairmanDavid R Guyer owns 70,113 units of Common Stock. In the year 2013 David R Guyer acquired a total of 727,447 shares in Ophthotech Corp. at a cost of $5,679,728.22, David also disposed a total of 703,894 shares of Ophthotech Corp. equalling to $30,100,801.78.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +12.75% | 7.93K |
$7.16 | -$66,373.20 | 70.11K |
Dec 12 - Dec 14
| |||
Form 4
| +15.21% | 8.21K |
$6.96 | -$66,829.92 | 62.18K |
Dec 9 - Dec 10
| |||
Form 4
| +5.64% | 2.88K |
$8.07 | -$27,171.69 | 53.97K |
Jan 4 - Jan 6
| |||
Form 4
| +18.36% | 7.92K |
$6.60 | -$61,215.00 | 51.09K |
Dec 12 - Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
| +5.86% | 2.39K |
$1.30 | -$5,016.70 | 43.16K |
Jan 4 - Jan 7
| |||
Form 4
| +5.47% | 2.11K |
$1.24 | -$4,509.88 | 40.77K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +6.77% | 2.45K |
$3.17 | -$12,039.66 | 38.66K |
Jan 4 - Jan 5
| |||
Form 4
| +6.58% | 2.23K |
$3.24 | -$11,391.84 | 36.21K |
Jan 2 - Jan 3
| |||
Form 4
| +69.75% | 13.96K |
$3.19 | -$52,698.80 | 33.97K |
Dec 29 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
| +177.51% | 12.8K |
$2.58 | -$45,609.24 | 20.01K |
Jun 30 - Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +51.93% | 2.46K |
$4.96 | -$18,773.60 | 7.21K |
Jan 4 - Jan 5
| |||
Form 4
| +91.33% | 2.27K |
$4.90 | -$17,071.60 | 4.75K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
$22.82 | -$564,376.60 | 2.48K |
Scheduled
|
Nov 1
| ||
Form 4
| -70.22% | -5.85K |
$27.20 | -$816,312.34 | 2.48K |
Scheduled
|
Oct 3
| ||
Form 4
| -74.28% | -24.06K |
$52.58 | -$1,265,074.80 | 8.33K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$37.25 | -$1,309,780.95 | 32.39K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$31.08 | -$1,012,612.00 | 32.39K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$31.37 | -$1,283,003.50 | 32.39K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$28.11 | -$797,476.39 | 32.39K |
Scheduled
|
May 2
| ||
Form 4
|
—
|
0
|
$27.07 | -$751,721.96 | 32.39K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$27.76 | -$782,048.24 | 32.39K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$31.83 | -$810,837.36 | 32.39K |
Scheduled
|
Jan 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +8.29% | 2.48K |
$72.54 | -$237,140.41 | 32.39K |
Jan 2 - Jan 4
| |||
Form 4
|
—
|
0
|
$44.43 | -$1,278,288.78 | 29.91K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$36.26 | -$974,754.34 | 29.91K |
Scheduled
|
Nov 30
| ||
Form 4
|
—
|
0
|
$29.96 | -$740,531.70 | 29.91K |
Scheduled
|
Oct 30
| ||
Form 4
|
—
|
0
|
$23.86 | -$514,060.63 | 29.91K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
$27.46 | -$647,672.88 | 29.91K |
Scheduled
|
Aug 31
| ||
Form 4
|
∞
| 29.91K |
$10.03 | $299,997.30 | 29.91K |
Aug 7
| |||
Form 4
|
—
|
0
|
$38.17 | -$1,046,039.36 |
0
|
Scheduled
|
Jul 30
| ||
Form 4
|
—
|
0
|
$30.54 | -$762,316.56 |
0
|
Scheduled
|
Jun 29
| ||
Form 4
|
—
|
0
|
$29.33 | -$717,138.12 |
0
|
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
$29.24 | -$713,917.72 |
0
|
Scheduled
|
Apr 29
| ||
Form 4
|
—
|
0
|
$29.15 | -$710,439.12 |
0
|
Scheduled
|
Mar 30
| ||
Form 4
|
—
|
0
|
$31.63 | -$802,609.31 |
0
|
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$31.62 | -$648,269.08 |
0
|
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$27.69 | -$530,904.74 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$25.81 | -$474,255.88 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$24.87 | -$446,197.34 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
| +0.41% | 50 |
$23.67 | -$332,937.21 | 12.28K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$24.28 | -$79,971.43 |
0
|
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$24.31 | -$31,604.85 |
0
|
Scheduled
|
Sep 4
| ||
Form 4
|
—
|
0
|
$23.86 | -$351,934.53 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$23.94 | -$365,442.72 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$25.56 | -$466,768.02 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
| -100.00% | -11.89K |
$24.98 | -$878,885.68 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
| -47.28% | -10.66K |
$33.71 | -$359,508.39 | 11.89K |
Scheduled
|
May 1
| ||
Form 4
| -34.78% | -12.03K |
$34.27 | -$412,220.99 | 22.56K |
Scheduled
|
Apr 1
| ||
Form 4
| -25.80% | -12.03K |
$34.53 | -$415,315.80 | 34.58K |
Scheduled
|
Mar 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APPLIED GENETIC TECHNOLOGIES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSI PHARMACEUTICALS INC No price found
Exec. VP & CEO (OSI) EyetechDavid R Guyer owns 144,628 units of Common Stock. In the year 2005 David R Guyer filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
∞
| 148.31K |
—
|
—
| 148.31K |
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||